colistimethate sodium has been researched along with Pneumonia, Bacterial in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benítez-Cano, A; Bermejo, S; Campillo, N; Carazo, J; de Antonio-Cuscó, M; Grau, S; Horcajada, JP; Luque, S; Ramos, I; Samsó, E; Sorlí, L | 1 |
Arenzana Seisdedos, Á; Cantón-Bulnes, ML; Garnacho-Montero, J; Hurtado Martínez, Á; López-Cerero, L; Merino-Bohorquez, V | 1 |
Alvarez-Lerma, F; Grau, S; Horcajada, JP; Luque, S; Segura, C; Sorlí, L; Valle, M | 1 |
Brownlee, K; Harnan, S; Mildred, M; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M | 1 |
Chen, FL; Hsieh, TC; Jean, SS; Lee, WS; Ou, TY | 1 |
Chae, SL; Chung, JW; Huh, HJ; Jeong, YJ; Kim, KS; Kwon, KH; Oh, JY; Park, SY; Shin, SJ; Yoon, YS | 1 |
Malacarne, P; Sbrana, F; Tascini, C; Viaggi, B | 1 |
Chokephaibulkit, K; Imberti, R; Nakwan, N; Regazzi, M; Usaha, S; Villani, P | 1 |
Bauldoff, GS; Mangino, JE; Nunley, DR; Pope-Harman, AL | 1 |
Angkasekwinai, N; Lorsutthitham, J; Rattanaumpawan, P; Thamlikitkul, V; Ungprasert, P | 1 |
Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ | 1 |
1 review(s) available for colistimethate sodium and Pneumonia, Bacterial
Article | Year |
---|---|
Ventilator-associated pneumonia caused by colistin-resistant KPC-producing Klebsiella pneumoniae: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Calcitonin; Calcitonin Gene-Related Peptide; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Equipment Contamination; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Pneumonia, Bacterial; Protein Precursors; Tigecycline; Treatment Outcome; Ventilators, Mechanical | 2015 |
1 trial(s) available for colistimethate sodium and Pneumonia, Bacterial
Article | Year |
---|---|
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome | 2010 |
9 other study(ies) available for colistimethate sodium and Pneumonia, Bacterial
Article | Year |
---|---|
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prospective Studies | 2019 |
A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia complex; Burkholderia Infections; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Lung Transplantation; Male; Pneumonia, Bacterial; Treatment Outcome; X-Rays | 2019 |
Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Plasma; Pneumonia, Bacterial | 2013 |
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Decision Support Techniques; Dry Powder Inhalers; Humans; Models, Economic; Pneumonia, Bacterial; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Tobramycin; Young Adult | 2014 |
Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2016 |
Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Colistin; Female; Humans; Incidence; Male; Middle Aged; Pneumonia, Bacterial; Renal Insufficiency; Retrospective Studies; Treatment Outcome | 2015 |
Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Bacteremia; Colistin; Critical Illness; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Pneumonia, Bacterial; Prospective Studies | 2016 |
Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Humans; Imipenem; Immunosuppressive Agents; Lung Transplantation; Minocycline; Pneumonia, Bacterial; Radiography; Retrospective Studies; Tigecycline | 2010 |
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins | 2012 |